For some time now you have been saying Dean should sell shares to finance the company. Now that he has done exactly what you said he should, you don’t like the deal? This money will finance the company for the next 12 months. The way Deans luck is, the FDA will give approval before the ink is dry. He has to prepare for the unknown and that is when the FDA will make a decision. Every time he calls the say” your file is still under review” Institutional investors are a positive in my book.
Market Data 
Markets 
AI
